Empagliflozin Effectively Lowers Liver Fat Content in Well-Controlled Type 2 Diabetes: A Randomized, Double-Blind, Phase 4, Placebo-Controlled Trial.

导出 LinkOut

翻译打印收藏纠错

第一作者： Sabine,Kahl

第一单位： Institute for Clinical Diabetology, German Diabetes Center, Leibniz Institute for Diabetes Research at Heinrich-Heine University, Düsseldorf, Germany.

作者： Sabine,Kahl ^[1] ; Sofiya,Gancheva ^[2] ; Klaus,Straßburger ^[1] ; Christian,Herder ^[2] ; Jürgen,Machann ^[3] ; Hisayuki,Katsuyama ^[2] ; Stefan,Kabisch ^[4] ; Elena,Henkel ^[1] ; Stefan,Kopf ^[2] ; Merit,Lagerpusch ^[2] ; Konstantinos,Kantartzis ^[5] ; Yuliya,Kupriyanova ^[1] ; Daniel,Markgraf ^[2] ; Theresa,van Gemert ^[2] ; Birgit,Knebel ^[6] ; Martin F,Wolkersdorfer ^[7] ; Oliver,Kuss ^[2] ; Jong-Hee,Hwang ^[8] ; Stefan R,Bornstein ^[2] ; Christian,Kasperk ^[6] ; Norbert,Stefan ^[2] ; Andreas,Pfeiffer ^[5] ; Andreas L,Birkenfeld ^[1] ; Michael,Roden ^[2]

作者单位： Institute for Clinical Diabetology, German Diabetes Center, Leibniz Institute for Diabetes Research at Heinrich-Heine University, Düsseldorf, Germany. ^[1] German Center for Diabetes Research, München-Neuherberg, Germany. ^[2] Division of Endocrinology and Diabetology, Medical Faculty, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany. ^[3] Institute for Biometrics and Epidemiology, German Diabetes Center, Leibniz Institute for Diabetes Research at Heinrich-Heine University, Düsseldorf, Germany. ^[4] Institute for Diabetes Research and Metabolic Diseases, Helmholtz Center Munich at the University of Tübingen, Tübingen, Germany. ^[5] Department of Clinical Nutrition, German Institute of Human Nutrition Potsdam-Rehbrücke, Nuthetal, Germany. ^[6] Clinical Study Center of Metabolic Vascular Medicine, GWT-TUD GmbH, Dresden, Germany. ^[7] Department of Internal Medicine 1 and Clinical Chemistry, University Hospital of Heidelberg, Heidelberg, Germany. ^[8] Institute for Clinical Biochemistry and Pathobiochemistry, German Diabetes Center, Leibniz Institute for Diabetes Research at Heinrich-Heine University, Düsseldorf, Germany. ^[9] Landesapotheke Salzburg, Salzburg, Austria. ^[10] Paul Langerhans Institute Dresden, Helmholtz Center Munich at University Hospital MKIII, and Faculty of Medicine, TU Dresden, Dresden, Germany. ^[11] Department of Endocrinology, Diabetes and Nutrition, Campus Benjamin Franklin, Charité University Medicine, Berlin, Germany. ^[12] Institute for Clinical Diabetology, German Diabetes Center, Leibniz Institute for Diabetes Research at Heinrich-Heine University, Düsseldorf, Germany michael.roden@ddz.de. ^[13]